<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33883225</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>13</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>SAMHD1 Inhibits Multiple Enteroviruses by Interfering with the Interaction between VP1 and VP2 Proteins.</ArticleTitle><Pagination><StartPage>e0062021</StartPage><MedlinePgn>e0062021</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00620-21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.00620-21</ELocationID><Abstract><AbstractText>Sterile alpha motif and histidine-aspartic acid domain-containing protein 1 (SAMHD1) possesses multiple biological activities such as virus restriction, innate immunity regulation, and autoimmunity. Our previous study demonstrated that SAMHD1 potently inhibits the replication of enterovirus 71 (EV71). In this study, we observed that SAMHD1 also restricts multiple enteroviruses (EVs), including coxsackievirus A16 (CA16) and enterovirus D68 (EVD68), but not coxsackievirus A6 (CA6). Mechanistically, SAMHD1 competitively interacted with the same domain in VP1 that binds to VP2 of EV71 and EVD68, thereby interfering with the interaction between VP1 and VP2 , and therefore viral assembly. Moreover, we showed that the SAMHD1 T592A mutant maintained the EV71 inhibitory effect by attenuating the interaction between VP1 and VP2, whereas the T592D mutant failed to. We also demonstrated that SAMHD1 could not inhibit CA6 because a different binding site is required for the SAMHD1 and VP1 interaction. Our findings reveal the mechanism of SAMHD1 inhibition of multiple EVs, and this could potentially be important for developing drugs against a broad range of EVs. <b>IMPORTANCE</b> Enterovirus causes a wide variety of diseases, such as hand, foot, and mouth disease (HFMD), which is a severe public problem threatening children under 5&#x2009;years. Therefore, identifying essential genes which restrict EV infection and exploring the underlying mechanisms are necessary to develop an effective strategy to inhibit EV infection. In this study, we report that host restrictive factor SAMHD1 has broad-spectrum antiviral activity against EV71, CA16, and EVD68 independent of its well-known deoxynucleoside triphosphate triphosphohydrolase (dNTPase) or RNase activity. Mechanistically, SAMHD1 restricts EVs by competitively interacting with the same domain in VP1 that binds to VP2 of EVs, thereby interfering with the interaction between VP1 and VP2, and therefore viral assembly. In contrast, we also demonstrated that SAMHD1 could not inhibit CA6 because a different binding site is required for the SAMHD1 and CA6 VP1 interaction. Our study reveals a novel mechanism for the SAMHD1 anti-EV replication activity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Zhilei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Zhaolong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huan</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wenyan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.5.-</RegistryNumber><NameOfSubstance UI="D000076106">SAM Domain and HD Domain-Containing Protein 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.5.-</RegistryNumber><NameOfSubstance UI="C484280">SAMHD1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000076106" MajorTopicYN="N">SAM Domain and HD Domain-Containing Protein 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019065" MajorTopicYN="N">Virus Assembly</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EVs</Keyword><Keyword MajorTopicYN="N">SAMHD1</Keyword><Keyword MajorTopicYN="N">VP1</Keyword><Keyword MajorTopicYN="N">novel mechanism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33883225</ArticleId><ArticleId IdType="pmc">PMC8316000</ArticleId><ArticleId IdType="doi">10.1128/JVI.00620-21</ArticleId><ArticleId IdType="pii">JVI.00620-21</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. 2011. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654&#x2013;657. 10.1038/nature10117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10117</ArticleId><ArticleId IdType="pmc">PMC3595993</ArticleId><ArticleId IdType="pubmed">21613998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. 2011. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658&#x2013;661. 10.1038/nature10195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10195</ArticleId><ArticleId IdType="pmc">PMC3179858</ArticleId><ArticleId IdType="pubmed">21720370</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Zhang W, Cao X. 2000. Identification of human homologue of mouse IFN-gamma induced protein from human dendritic cells. Immunol Lett 74:221&#x2013;224. 10.1016/S0165-2478(00)00276-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-2478(00)00276-5</ArticleId><ArticleId IdType="pubmed">11064105</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de Carvalho LP, Stoye JP, Crow YJ, Taylor IA, Webb M. 2011. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379&#x2013;382. 10.1038/nature10623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10623</ArticleId><ArticleId IdType="pubmed">22056990</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci JM, St Gelais C, de Silva S, Yount JS, Tang C, Ji X, Shepard C, Xiong Y, Kim B, Wu L. 2016. SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity. Nat Med 22:1072&#x2013;1074. 10.1038/nm.4163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4163</ArticleId><ArticleId IdType="pmc">PMC5069697</ArticleId><ArticleId IdType="pubmed">27711056</ArticleId></ArticleIdList></Reference><Reference><Citation>Beloglazova N, Flick R, Tchigvintsev A, Brown G, Popovic A, Nocek B, Yakunin AF. 2013. Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. J Biol Chem 288:8101&#x2013;8110. 10.1074/jbc.M112.431148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.431148</ArticleId><ArticleId IdType="pmc">PMC3605629</ArticleId><ArticleId IdType="pubmed">23364794</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Ryoo J, Oh C, Hwang S, Ahn K. 2015. SAMHD1 specifically restricts retroviruses through its RNase activity. Retrovirology 12:46. 10.1186/s12977-015-0174-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12977-015-0174-4</ArticleId><ArticleId IdType="pmc">PMC4450836</ArticleId><ArticleId IdType="pubmed">26032178</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryoo J, Choi J, Oh C, Kim S, Seo M, Kim SY, Seo D, Kim J, White TE, Brandariz-Nunez A, Diaz-Griffero F, Yun CH, Hollenbaugh JA, Kim B, Baek D, Ahn K. 2014. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med 20:936&#x2013;941. 10.1038/nm.3626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3626</ArticleId><ArticleId IdType="pmc">PMC4318684</ArticleId><ArticleId IdType="pubmed">25038827</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci JM, Kim SH, St Gelais C, Bonifati S, Li TW, Buzovetsky O, Knecht KM, Duchon AA, Xiong Y, Musier-Forsyth K, Wu L. 2018. SAMHD1 impairs HIV-1 gene expression and negatively modulates reactivation of viral latency in CD4(+) T cells. J Virol 92:e00292-18. 10.1128/JVI.00292-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00292-18</ArticleId><ArticleId IdType="pmc">PMC6052313</ArticleId><ArticleId IdType="pubmed">29793958</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Zhu M, Pan X, Zhu Y, Yan H, Jiang T, Shen Y, Dong X, Zheng N, Lu J, Ying S, Shen Y. 2014. Inhibition of hepatitis B virus replication by SAMHD1. Biochem Biophys Res Commun 450:1462&#x2013;1468. 10.1016/j.bbrc.2014.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2014.07.023</ArticleId><ArticleId IdType="pubmed">25019997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollenbaugh JA, Gee P, Baker J, Daly MB, Amie SM, Tate J, Kasai N, Kanemura Y, Kim DH, Ward BM, Koyanagi Y, Kim B. 2013. Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathog 9:e1003481. 10.1371/journal.ppat.1003481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003481</ArticleId><ArticleId IdType="pmc">PMC3694861</ArticleId><ArticleId IdType="pubmed">23825958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim ET, White TE, Brandariz-Nunez A, Diaz-Griffero F, Weitzman MD. 2013. SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication. J Virol 87:12949&#x2013;12956. 10.1128/JVI.02291-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02291-13</ArticleId><ArticleId IdType="pmc">PMC3838123</ArticleId><ArticleId IdType="pubmed">24067963</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer AF, Riviere L, Qu B, Schott K, Riess M, Ni Y, Shepard C, Schnellbacher E, Finkernagel M, Himmelsbach K, Welzel K, Kettern N, Donnerhak C, Munk C, Flory E, Liese J, Kim B, Urban S, Konig R. 2016. Restrictive influence of SAMHD1 on hepatitis B virus life cycle. Sci Rep 6:26616. 10.1038/srep26616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep26616</ArticleId><ArticleId IdType="pmc">PMC4882586</ArticleId><ArticleId IdType="pubmed">27229711</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze A, Belgnaoui SM, Olagnier D, Lin R, Hiscott J, van Grevenynghe J. 2013. Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis. Cell Host Microbe 14:422&#x2013;434. 10.1016/j.chom.2013.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.09.009</ArticleId><ArticleId IdType="pubmed">24139400</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, Pancino G, Priet S, Canard B, Laguette N, Benkirane M, Transy C, Landau NR, Kim B, Margottin-Goguet F. 2012. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 13:223&#x2013;228. 10.1038/ni.2236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2236</ArticleId><ArticleId IdType="pmc">PMC3771401</ArticleId><ArticleId IdType="pubmed">22327569</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell RD, Holland PJ, Hollis T, Perrino FW. 2011. Aicardi-Gouti&#xe8;res syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. J Biol Chem 286:43596&#x2013;43600. 10.1074/jbc.C111.317628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C111.317628</ArticleId><ArticleId IdType="pmc">PMC3243528</ArticleId><ArticleId IdType="pubmed">22069334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballana E, Este JA. 2015. SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction. Trends Microbiol 23:680&#x2013;692. 10.1016/j.tim.2015.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2015.08.002</ArticleId><ArticleId IdType="pubmed">26439297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YH, Jeang KT, Tokunaga K. 2012. Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology 9:112. 10.1186/1742-4690-9-112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-9-112</ArticleId><ArticleId IdType="pmc">PMC3549941</ArticleId><ArticleId IdType="pubmed">23254112</ArticleId></ArticleIdList></Reference><Reference><Citation>Coquel F, Silva MJ, Techer H, Zadorozhny K, Sharma S, Nieminuszczy J, Mettling C, Dardillac E, Barthe A, Schmitz AL, Promonet A, Cribier A, Sarrazin A, Niedzwiedz W, Lopez B, Costanzo V, Krejci L, Chabes A, Benkirane M, Lin YL, Pasero P. 2018. SAMHD1 acts at stalled replication forks to prevent interferon induction. Nature 557:57&#x2013;61. 10.1038/s41586-018-0050-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0050-1</ArticleId><ArticleId IdType="pubmed">29670289</ArticleId></ArticleIdList></Reference><Reference><Citation>Daddacha W, Koyen AE, Bastien AJ, Head PE, Dhere VR, Nabeta GN, Connolly EC, Werner E, Madden MZ, Daly MB, Minten EV, Whelan DR, Schlafstein AJ, Zhang H, Anand R, Doronio C, Withers AE, Shepard C, Sundaram RK, Deng X, Dynan WS, Wang Y, Bindra RS, Cejka P, Rothenberg E, Doetsch PW, Kim B, Yu DS. 2017. SAMHD1 promotes DNA end resection to facilitate DNA repair by homologous recombination. Cell Rep 20:1921&#x2013;1935. 10.1016/j.celrep.2017.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.08.008</ArticleId><ArticleId IdType="pmc">PMC5576576</ArticleId><ArticleId IdType="pubmed">28834754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Huan C, Wang H, Liu Y, Liu X, Su X, Yu J, Zhao Z, Yu XF, Zheng B, Zhang W. 2020. TRIM21-mediated proteasomal degradation of SAMHD1 regulates its antiviral activity. EMBO Rep 21:e47528. 10.15252/embr.201847528.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201847528</ArticleId><ArticleId IdType="pmc">PMC6944907</ArticleId><ArticleId IdType="pubmed">31797533</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating J, van Kuppeveld FJM. 2018. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol 16:368&#x2013;381. 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox JA, Hiscox JA, Solomon T, Ooi MH, Ng LFP. 2017. Immunopathogenesis and virus-host interactions of enterovirus 71 in patients with hand, foot and mouth disease. Front Microbiol 8:2249. 10.3389/fmicb.2017.02249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02249</ArticleId><ArticleId IdType="pmc">PMC5713468</ArticleId><ArticleId IdType="pubmed">29238324</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X, Wan Z, Li Y, Hu Y, Jin X, Zhang C. 2020. National epidemiology and evolutionary history of four hand, foot and mouth disease-related enteroviruses in China from 2008 to 2016. Virol Sin 35:21&#x2013;33. 10.1007/s12250-019-00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00169-2</ArticleId><ArticleId IdType="pmc">PMC7035399</ArticleId><ArticleId IdType="pubmed">31664644</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm-Hansen CC, Midgley SE, Fischer TK. 2016. Global emergence of enterovirus D68: a systematic review. Lancet Infect Dis 16:e64&#x2013;e75. 10.1016/S1473-3099(15)00543-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00543-5</ArticleId><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Li L, Ren L, Guo L, Xie Z, Liu C, Li T, Luo M, Paranhos-Baccala G, Xu W, Wang J. 2017. Seroepidemiology of enterovirus D68 infection in China. Emerg Microbes Infect 6:e32. 10.1038/emi.2017.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2017.14</ArticleId><ArticleId IdType="pmc">PMC5520479</ArticleId><ArticleId IdType="pubmed">28487560</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Liu Y, Lyoo H, van Vliet ALW, Wahedi M, de Bruin JW, Roberts RW, Overduin P, Meijer A, Rossmann MG, Thibaut HJ, van Kuppeveld FJM. 2019. Bypassing pan-enterovirus host factor PLA2G16. Nat Commun 10:3171. 10.1038/s41467-019-11256-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11256-z</ArticleId><ArticleId IdType="pmc">PMC6639302</ArticleId><ArticleId IdType="pubmed">31320648</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Ning S, Su X, Liu X, Wang H, Liu Y, Zheng W, Zheng B, Yu XF, Zhang W. 2018. Enterovirus 71 antagonizes the inhibition of the host intrinsic antiviral factor A3G. Nucleic Acids Res 46:11514&#x2013;11527. 10.1093/nar/gky840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky840</ArticleId><ArticleId IdType="pmc">PMC6265463</ArticleId><ArticleId IdType="pubmed">30247716</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Zheng Q, Wang Y, Pang Z, Liu J, Yin Z, Lou Z. 2019. Activity-based protein profiling identifies ATG4B as a key host factor for enterovirus 71 proliferation. J Virol 93:e01092-19. 10.1128/JVI.01092-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01092-19</ArticleId><ArticleId IdType="pmc">PMC6880168</ArticleId><ArticleId IdType="pubmed">31554687</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Li JX, Jin PF, Wang YX, Zhu FC. 2016. Enterovirus 71: a whole virion inactivated enterovirus 71 vaccine. Expert Rev Vaccines 15:803&#x2013;813. 10.1080/14760584.2016.1191357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2016.1191357</ArticleId><ArticleId IdType="pubmed">27206811</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, Perera R, Cardosa J, Kuhn RJ, Rossmann MG. 2012. Crystal structure of human enterovirus 71. Science 336:1274. 10.1126/science.1218713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1218713</ArticleId><ArticleId IdType="pmc">PMC3448362</ArticleId><ArticleId IdType="pubmed">22383808</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Peng W, Ren J, Hu Z, Xu J, Lou Z, Li X, Yin W, Shen X, Porta C, Walter TS, Evans G, Axford D, Owen R, Rowlands DJ, Wang J, Stuart DI, Fry EE, Rao Z. 2012. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat Struct Mol Biol 19:424&#x2013;429. 10.1038/nsmb.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S, Li G, Wang Y, Gao Q, Wang Y, Cui R, Altmeyer R, Zou G. 2016. Identification of positively charged residues in enterovirus 71 capsid protein VP1 essential for production of infectious particles. J Virol 90:741&#x2013;752. 10.1128/JVI.02482-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02482-15</ArticleId><ArticleId IdType="pmc">PMC4702679</ArticleId><ArticleId IdType="pubmed">26512078</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu K, He YL, Li HY, Chen R. 2015. Crystal structures of yeast-produced enterovirus 71 and enterovirus 71/coxsackievirus a16 chimeric virus-like particles provide the structural basis for novel vaccine design against hand-foot-and-mouth disease. J Virol 89:6196&#x2013;6208. 10.1128/JVI.00422-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00422-15</ArticleId><ArticleId IdType="pmc">PMC4474312</ArticleId><ArticleId IdType="pubmed">25833050</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandler-Bostock R, Mata CP, Bingham RJ, Dykeman EC, Meng B, Tuthill TJ, Rowlands DJ, Ranson NA, Twarock R, Stockley PG. 2020. Assembly of infectious enteroviruses depends on multiple, conserved genomic RNA-coat protein contacts. PLoS Pathog 16:e1009146. 10.1371/journal.ppat.1009146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009146</ArticleId><ArticleId IdType="pmc">PMC7793301</ArticleId><ArticleId IdType="pubmed">33370422</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathinayake PS, Hsu AC, Wark PA. 2015. Innate immunity and immune evasion by enterovirus 71. Viruses 7:6613&#x2013;6630. 10.3390/v7122961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122961</ArticleId><ArticleId IdType="pmc">PMC4690884</ArticleId><ArticleId IdType="pubmed">26694447</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden L, Wolthers KC, van Kuppeveld FJ. 2015. Replication and inhibitors of enteroviruses and parechoviruses. Viruses 7:4529&#x2013;4562. 10.3390/v7082832.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7082832</ArticleId><ArticleId IdType="pmc">PMC4576193</ArticleId><ArticleId IdType="pubmed">26266417</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YX, Huang YM, Li QJ, Li XY, Zhou YD, Guo F, Zhou JM, Cen S. 2017. A highly conserved amino acid in VP1 regulates maturation of enterovirus 71. PLoS Pathog 13:e1006625. 10.1371/journal.ppat.1006625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006625</ArticleId><ArticleId IdType="pmc">PMC5634653</ArticleId><ArticleId IdType="pubmed">28938017</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon V, Bloch N, Landau NR. 2015. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat Immunol 16:546&#x2013;553. 10.1038/ni.3156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3156</ArticleId><ArticleId IdType="pmc">PMC6908429</ArticleId><ArticleId IdType="pubmed">25988886</ArticleId></ArticleIdList></Reference><Reference><Citation>Usami Y, Wu Y, Gottlinger HG. 2015. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature 526:218&#x2013;223. 10.1038/nature15400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15400</ArticleId><ArticleId IdType="pmc">PMC4600458</ArticleId><ArticleId IdType="pubmed">26416733</ArticleId></ArticleIdList></Reference><Reference><Citation>Mlcochova P, Sutherland KA, Watters SA, Bertoli C, de Bruin RA, Rehwinkel J, Neil SJ, Lenzi GM, Kim B, Khwaja A, Gage MC, Georgiou C, Chittka A, Yona S, Noursadeghi M, Towers GJ, Gupta RK. 2017. A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages. EMBO J 36:604&#x2013;616. 10.15252/embj.201696025.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696025</ArticleId><ArticleId IdType="pmc">PMC5331754</ArticleId><ArticleId IdType="pubmed">28122869</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu N, Yang J, Zheng B, Zhang Y, Cao Y, Huan C, Wang S, Chang J, Zhang W. 2020. The pyrimidine analog FNC potently inhibits the replication of multiple enteroviruses. J Virol 94:e00204-20. 10.1128/JVI.00204-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00204-20</ArticleId><ArticleId IdType="pmc">PMC7163137</ArticleId><ArticleId IdType="pubmed">32075935</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Du J, Evans SL, Yu Y, Yu XF. 2011. T-cell differentiation factor CBF-beta regulates HIV-1 Vif-mediated evasion of host restriction. Nature 481:376&#x2013;379. 10.1038/nature10718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10718</ArticleId><ArticleId IdType="pubmed">22190036</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>